Trial Details

Recruiting
Basic Information
Clinical ID c5185
Identifier DRKS00019082
Trial Title Analysis of clinical, genetical, immunological and microbial factors in IBD patients to identify new prognostic and predictive factors to further optimize and personalize IBD management - The SIGMOID Study
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions K50.1.Ulcerative colitis K50 K51;Crohn disease [regional enteritis];Ulcerative colitis
Interventions Group 1: IBD (inflammatory bowel disease) patients under Infliximab therapyGroup 2: IBD patients under Vedolizumab therapyGroup 3: IBD patients under Ustekinumab therapy
Participant Information
Sponsor Medizinische Hochschule Hannover
City NULL
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type observational
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL